Europe Veterinary Healthcare market Segmented by Products Animal diagnostic technologies, Animal genetics, By animal types Trends & Forecasts (2016-2021)

1. INTRODUCTION

1.1 Market Definition

1.2 Market Recent Trends

  2 Market Analysis

2.1 Market Animal Health Products

2.2 Animal medicines vs. human Medicines

  3. Market Dynamics

3.1 Market Drivers

3.1.1 Increase in pet ownership

3.1.2 Improved Nutrition

3.1.3 Intensifying consumer focus on food safety

3.1.4 Greater Livestock production

3.1.5 Increasing Zoonotic and Foodborne Diseases

3.2 Market Constraints

3.2 1 Scarcity of arable land and water

3.2.2 Increased competition for cultivated land

3.2.3 Cost-effective production

3.3 Porter's Five Force Analysis

3.3.1 Threat of New Entrant

3.3.2 Internal Rivalry

3.3.3 Buyer bargaining power

3.3.4 Supplier bargaining power

3.3.5 Threat of substitutes

  4. Europe Veterinary healthcare Market Segmentation- Animal Types, based on products

4.1 Companion Animal health

4.1.1 Vaccines

4.1.2 Parasiticides

4.1.3 Anti-Infectives

4.1.4 Medicinal Feed Additives

4.1.5 Other Pharmaceuticals

4.2 Farm Animals

4.2.1 Vaccines

4.2.2 Parasiticides

4.2.3 Anti-Infectives

4.2.4 Medicinal Feed additives

4.2.5 Other Pharmaceuticals

  5. Europe Veterinary Diagnostics Market

5.1 Enzyme Linked Immuno Sorbent Assay (ELISA)

5.2 Rapid Immuno Migration (RIM)

5.3 Agar gel Immuno Diffusion (AGID)

  6. Europe Veterinary Genetics Market

6.1 HD 50K for Angus

6.2 CLARIFIDE® for Dairy

6.3 Sheep 50K

6.4 CLARIFIDE® for Nelore

  7. Europe Veterinary Healthcare Market Segmentation- By Animal Species

7.1 Farm animal

7.1.1 Cattle

7.1.2 Swine

7.1.3 Poultry

7.1.4 Fish

7.1.5 Sheep

7.2 Companion Animals

7.2.1 Dogs

7.2.2 Cats

7.2.3 Horses

8. Europe Veterinary healthcare market- Country-level Analysis

8.1 France

8.2 Germany

8.3 Italy

8.4 Spain

8.5 Sweden

9. Competitive landscape

9.1 Major players in the market

9.2 Mergers and acquisitions

9.3 New product launches

9.4 Agreement, Collaborations, and Partnerships

  10. Company profiles

10.1 Zoetis animal healthcare

10.1.1 Financial Overview

10.1.2 Business overview

10.1.3 Business strategies

10.2 Merck

10.2.1 Financial Overview

10.2.2 Business overview

10.2.3 Business strategies

10.3 Merial (Animal Health Division of Sanofi)

10.3.1 Financial Overview

10.3.2 Business overview

10.3.3 Business strategies

10.4 Elanco

10.4.1 Financial Overview

10.4.2 Business overview

10.4.3 Business strategies

10.5 Bayer healthcare

10.5.1 Financial Overview

10.5.2 Business overview

10.5.3 Business strategies

10.6 Ceva Animal Health, Inc.

10.6.1 Financial Overview

10.6.2 Business overview

10.6.3 Business strategies

10.7 Virbac

10.7.1 Financial Overview

10.7.2 Business overview

10.7.3 Business strategies

10.8 Boehringer Ingelheim

10.8.1 Financial Overview

10.8.1 Business overview

10.8.1 Business strategies

11. Appendix

11.1. Abbreviations

11.2. Sources

11.3. Bibliography

11.4. Disclaimer